Malaria is an important global disease that threatened human life. The resistance Plasmodium sp. to the available medicines encourages the search for new antimalarial substances based on new mechanisms on the inhibition of PfMQO (the mitochondrial Plasmodium falciparum enzyme). Objective: The purposes of this study was to screen antimalarial substances from microalgae based on the inhibition of PfMQO. Materials and Methods: Five microalgae were extracted by maceration using chloroform pa and ethanol pa. These ten crude extracts obtained were tested for the inhibitory activity against the PfMQO enzyme. Results: The highest inhibitory activity against PfMQO enzyme was chloroform extract of S. costatum with 91.050% of inhibition and 0.043 µg/mL of IC 50 . The ethanol extract of S. platensis showed 91.999% and 5.25 µg/mL of inhibition and IC 50 , respectively. These results indicated that the two extracts provide high antimalarial activity exceeded a theoretical standard of antimalarial bioactive compounds. Conclusion: Chloroform extract of S. costatum and ethanol extract of S. platensis are promising sources of antimalarial compounds based on the inhibition of PfMQO.
INTRODUCTION
Malaria is one of the world's health problems as almost half of the world's population is in the risk of malarial infection. This disease causes the mortality of 445,000 annually. 1 The disease is caused by the Plasmodium parasite infecting human erythrocytes through the bite of female Anopheles mosquito. 1 Plasmodium falciparum is the most dangerous species that can infect all erythrocyte stages, attacking all ages and sexes, including the most susceptible of pregnant women and children. 1 The incident of malaria is very high, causing severe complications to the patients, including shock, cerebral malaria, acute kidney failure, intravascular hemolysis, pulmonary edema and cause of deaths as the most. 2, 3 The emergence of various side effects in patients and the resistance to P. falciparum parasites due to the use of available commercial drugs so far have encouraged the search for a new and more effective source of anti P. falciparum compounds. Based on the different mechanism of action, screening of antimalarial compound hopefully discover the new anti-P. falciparum compound without triggering the resistance and with a minor side effect. 4 Microalgae contain various bioactive compounds with numerous biological activities that have been isolated and used for pharmaceutical industrial purposes. 5 Microalgae and cyanobacteria produce new bioactive compounds with various activities such as acetogenin, bromophenol, fatty acids, terpenes, sterols, alkaloids, 5,6 stanols, isoprenoids, terpenoids, steroid, phenolic compounds, acrylic acid and alkaloid 7 , neopphytadiene and phytol 8 , heptadecane and tetradecane. 9 The lipopeptide and various bioactive contents possess activities of cytotoxic (41%), antitumor (13%), antiviral (4%), antibiotics (12%), and the remaining 18% provide activities of antimalarial, antifungal, multi-drug resistance reversers, antifeedant and immunosuppressive agents, and also increase immunity and metabolism. 6 Nostoc sp. contains fukosianin that inhibits the growth of P. falciparum with IC 50 of 8.4 µg/mL.³ Lyngbya aestuarii Liebm provides antimalarial activity with IC 50 of 18.18 µg / mL, whereas the Oscillatoria baryana also exhibits such activity with IC 50 of 51 mg/mL against P. falciparum Pf3D7. 10 MQO (Malate quinone oxidoreductase) is an enzyme that plays a role in the electron transport process of P. falciparum mitochondria. These enzymes are some of the keys to energy production. The P. falciparum MQO (PfMQO) are specific targets to evaluate the inhibitory activity of substances against P. falciparum. That is part of both mitochondrial ETC and TCA cycle, substituting other mitochondrial malate dehydrogenase. [11] [12] [13] [14] [15] This specific target minimizes the side effect because such pathways are not available in humans. 16 PfMQO catalyzes the oxidation of L-malate to oxaloacetate and simultaneously reduces the ubiquinone to ubiquinol. It is proven that this membrane protein is important for the survival of P. falciparum within the intra-erythrocytic asexual stage because it is involved in three pathways: ETC, tricarboxylic acid and fumarate cycle. [17] [18] [19] [20] The inhibition of mitochondrial enzymes of P. falciparum without disturbing the function of human mitochondrial is a new promising action mechanism to overcome the resistance and negative side effects of medicines in patients. 4 Up to now, the study of microalgae extracts from Spirulina platensis, Chlorella vulgaris, Skeletonema costatum, Chaetoceros calcitrans and Nannochloropsis occulata to inhibit the growth of P. falciparum by specific enzyme inhibiting mechanism of PfMQO have not been carried out yet. Therefore, this study was conducted to screen the antimalarial activity of the microalgae extracts as the sources of anti P. falciparum based on the inhibition of PfMQO.
MATERIALS AND METHODS

Microalgae samples
S. platensis, C. vulgaris, and S. costatum were cultivated at the Brackish Water Aquaculture Center in Jepara, Indonesia, while C. calcitrans and N. occulata were cultivated at the Brackish Water Aquaculture Center in Situbondo, Indonesia. Dried microalgae powders were obtained from both centers.
PfMQO enzymes
The PfMQO enzyme was provided by the Technology Assessment and Application Agency, Ministry of Research, Technology and Higher Education, Indonesia.
Extraction
Each microalgae powder of 310 g, was macerated in 700 ml chloroform pa, stirred at 800 rpm (30 minutes), and soaked for 24 hours. Then, the solution was filtered using the Buchner funnel to obtain the first filtrate. The retentates were macerated with chloroform pa as much as 500 ml, stirred at 800 rpm and left to stand for 24 hours to obtain the second filtrate. The two filtrates were combined and evaporated using a Rotary Vacuum Evaporator at a temperature of 50ºC. Remaining retentates were subsequently macerated with 700 ml ethanol and stirred for 30 minutes at 800 rpm, and left to stand for 24 hours. After being filtered, the obtained ethanolic extract was evaporated and stored in refrigerator until used. 21 
Screening of inhibitors
Recombinant PfMQO used for screening several inhibitors and parasitic agents. The dried microalgae extracts were solubilized in methanol at a concentration of 0.02 mg/ml and sonicated for 5 minutes at 37°C by using a sonicator (AsOne sonicator, Japan). Due to the same principle employed by both assays, screening of PfMQO inhibitors adapted from the end-point assay method reported for Pf DHODH. 22, 23 An assay mix composed of HEPES KOH pH 7.5, 20 µL 1 mM KCN, 8,3 µL 60 mM d-UQ (decylubiquinone), 200 µL 12 mM DCIP (blue) and 5.3 μL of PfMQO-membrane fraction was prepared. Next, 193 μl of assay mix was transferred to a 96-well plate containing 2 μl (10 μM) or 0.5 μl (2.5 μM) of 1 mM inhibitors (columns 2 to 11) or DMSO [column 1, negative control (0% inhibition)], mixed well and background recorded for 5 min at 600 nm and 37 °C using SpectraMax® Paradigm® Multi-Mode Microplate Reader (Molecular Devices). To start the reaction, five μl of 400 mM L-malate was added, mixed well and after 8 min the activity was recorded. The column 12 of 96-well plate was set as a positive control (100% inhibition), and the substrate was not added. The PfMQO inhibition was determined by end-point measurement at 8 min and analyzed by calculating the inhibition (%) relative to negative and positive controls, in duplo. The results were stated as active sample when the inhibitory activity value (IC 50 ) obtained was greater than 50%. The inhibition value was calculated based on the following formula: 4, 24, 25 
RESULTS AND DISCUSSIONS
Screening of antimalarial activity from microalgae
This paper describes the antimalarial activity of several microalgae based on the inhibitory activity against PfMQO enzyme. The results of the primary screening for antimalarial activities from ten crude extract showed that all of the crude extracts exhibited inhibition activity against PfMQO enzyme. In the first screening, we found that from a total of ten extracts, seven extracts (S. platensis, C. vulgaris, S. costatum, C. calcitrans, N.occulata chloroform extracts, and S. platensis, S. costatum ethanol extracts) exhibited high antimalarial activities. The ethanolic extract of S. platensis exhibited the highest antimalarial activity with inhibition activity of 91.99% at 320 µg/ml. The second and the third highest antimalarial activities were shown by the chloroform and ethanolic extracts of S. costatum. Chloroform and ethanol extracts of S. costatum showed 91.050% and 86.830% inhibition activities at 320µg/ml, respectively. High antimalarial activities were also shown by C. calcitrans chloroform extract with inhibition activity of 81.634% at 320 µg/ml, S. platensis chloroform extract with inhibition activity of 76.926%, C. vulgaris with inhibition activity of 76.844% and N. occulata chloroform extract with inhibition activity of 68.468% (Table 1) .
A further experiment was conducted to evaluate dose-dependent activity of each extract. Generally, all extracts showed dose-dependent inhibiting-activity of PfMQO.
The all extracts showed dose-dependent inhibiting activity of PfMQO with coefficients correlation more than 0.9 (Figures 1-5 ) except chloroform extract of S. costatum (Figure 3 ). Based on the dosedependent curve, the IC 50 were calculated ( Table 2 ).
The PfMQO enzyme plays a fundamental role in P. falciparum mitochondria, but this enzyme is not present in the mitochondrial human system, so the discovered drug based on this mechanism provide no any interference or side effects to the host. 4 This was a new mechanism on the target treatment of antimalarial compouds. 4 By inhibiting PfMQO enzyme, the mitochondrial electron transport chain (ETC) of P. falciparum does not occur. PfMQO catalyzed the oxidation of L-malate to oxaloacetate and the simultaneous reduction of ubiquinone to ubiquinol. This membrane protein was important for the survival of P. falciparum within the intra-erythrocytic asexual stage because it was involved in three pathways: ETC, tricarboxylic acid cycle and fumarate cycle. [17] [18] [19] The process of inhibition of the development of P. falciparum through inhibition of the energy transfer processes within the mitochondria without disturbing its host was a new mechanism Bioactive compounds are categorized to be active and potent for antimalarials when the IC 50 values of the compound less than 10 µg/ mL, and to be moderate active when their IC 50 values range from 10 µg/ mL to 50 µg/mL, but will be categorized as inactive compound when IC 50 values are more than 50 µg/mL. 26 This work discovered that S. costatum and S. platensis were two promising sources of antimalarial compound for developing new antimalarial drugs. Further purification process should be carried out to obtain purified substance for chemical structure elucidation and further study on the bioactivity.
ACKNOWLEDGEMENT
We appreciated the Brachiswater Aquaculture Centre in Jepara and Situbondo, Indonesia, for providing the samples of microalgae. Thank you to the Sub Laboratory of Hydrobiology, Department of Fisheries, Faculty of Agriculture Universitas Gadjah Mada for providing assistance to prepare the sample extraction; Technology Assesment and Application Agency, Republic of Indonesia for providing PfMQO enzyme.
